Gastrointestinal Featured Articles

1. Allergan's Open Science Business Model Leads To Successful IBS Study 3/17/2016

   In January 2016, The New England Journal of Medicine published the results of a pivotal Phase 3 study of VIBERZI (eluxadoline), a treatment for adults suffering from irritable bowel syndrome (IBS) with diarrhea. The results were from two randomized, multicenter and multinational double-blind, placebo-controlled trials.

2. Can You Guess What This Trial Is Using To Fight Obesity? 1/12/2016

   A promising new diet may work wonders for helping individuals lose weight and fight obesity. The trial will involve taking fecal matter from the digestive tracts of healthy and thin humans, which would then be freeze-dried and put in a pill. Individuals in the study would then ingest the pills. The research does have some validity. Researchers at the Massachusetts General Hospital in Boston have discovered the microbes in digestive tracts of healthy individuals are different from those in obese individuals.